Graft-Versus-Host Disease – Moffitt Cancer Center researchers test drug comb…

A trial on alternate treatment approaches to reduce the risks of GvHD following allogeneic stem cell transplants. I had the current standard (combination of Tacrolimus and methotrexate); the study shows that a Tacrolimus/sirolimus combination may be more effective). An article for the interested.

Graft-Versus-Host Disease – Moffitt Cancer Center researchers test drug comb….

About these ads

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s